Literature DB >> 6850667

Phase II trial of etoposide in adenocarcinomas of the upper gastrointestinal tract.

D P Kelsen, G B Magill, E Cheng, M Dukeman, P Sordillo, R Heelan, A Yagoda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6850667

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  4 in total

1.  Phase II protocol for the evaluation of new treatments in patients with advanced gastric carcinoma: results of ECOG 5282.

Authors:  Y Novik; L M Ryan; D G Haller; R Asbury; J P Dutcher; A Schutt
Journal:  Med Oncol       Date:  1999-12       Impact factor: 3.064

2.  VM-26 in gastric cancer. A Southwest Oncology Group study.

Authors:  J L Berenberg; C Tangen; J S Macdonald; B Barlogie; L R Laufman
Journal:  Invest New Drugs       Date:  1993-11       Impact factor: 3.850

3.  Esophageal cancer chemotherapy: recent advances.

Authors:  David H Ilson
Journal:  Gastrointest Cancer Res       Date:  2008-03

4.  The effectiveness of a combination of etoposide/adriamycin/cisplatin (EAP) against inoperable gastric cancer--report of a histologically proven case.

Authors:  H Tahara; M Ogawa; Y Kido; H Shiozaki; I Ohashi; T Mori; M Sakurai
Journal:  Jpn J Surg       Date:  1991-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.